Sawicki PT - Search Results

1

Spectrum of Diabetes Research does not Reflect Patients' Scientific Preferences: A Longitudinal Evaluation of Diabetes Research Areas 2010-2013 vs. a Cross-sectional Survey in Patients with Diabetes.

Arnolds S, Heckermann S, Heise T, Sawicki PT. Arnolds S, et al. Among authors: sawicki pt. Exp Clin Endocrinol Diabetes. 2015 May;123(5):299-302. doi: 10.1055/s-0034-1398591. Epub 2015 Feb 6. Exp Clin Endocrinol Diabetes. 2015. PMID: 25658664

2

Comment on Retnakaran et al. Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: the LIBRA trial. Diabetes Care 2014;37:3270-3278.

Arnolds S, Sawicki PT. Arnolds S, et al. Among authors: sawicki pt. Diabetes Care. 2015 Feb;38(2):e25. doi: 10.2337/dc14-2418. Diabetes Care. 2015. PMID: 25614698 No abstract available.

3

Quality scores do not predict discrepant statistical significances among meta-analyses on different targets of glycemic control in type 2 diabetes.

Passon AM, Drabik A, Sawicki PT. Passon AM, et al. Among authors: sawicki pt. J Clin Epidemiol. 2013 Dec;66(12):1356-66. doi: 10.1016/j.jclinepi.2013.06.006. Epub 2013 Sep 7. J Clin Epidemiol. 2013. PMID: 24018347 Review.

4

[Comment: Hurdles for comparative effectiveness research in Germany].

Sawicki PT. Sawicki PT. Z Evid Fortbild Qual Gesundhwes. 2012;106(7):492-5. doi: 10.1016/j.zefq.2012.07.003. Epub 2012 Aug 10. Z Evid Fortbild Qual Gesundhwes. 2012. PMID: 22981025 German. No abstract available.

5

How do patients' preferences compare to the present spectrum of diabetes research?

Arnolds S, Heckermann S, Koch C, Heissmann N, Sawicki PT. Arnolds S, et al. Among authors: sawicki pt. Exp Clin Endocrinol Diabetes. 2013 Jan;121(1):60-3. doi: 10.1055/s-0032-1323776. Epub 2012 Sep 12. Exp Clin Endocrinol Diabetes. 2013. PMID: 22972031

6

Screening for diabetes: hope and despair.

Sawicki PT. Sawicki PT. Diabetologia. 2012 Jun;55(6):1568-71. doi: 10.1007/s00125-012-2553-x. Epub 2012 Apr 19. Diabetologia. 2012. PMID: 22526615

7

[The methods within the evaluation of disease management programmes in control-group designs using the example of diabetes mellitus - a systematic literature review].

Drabik A, Sawicki PT, Müller D, Passon A, Stock S. Drabik A, et al. Among authors: sawicki pt. Gesundheitswesen. 2012 Aug;74(8-9):496-501. doi: 10.1055/s-0031-1301273. Epub 2012 Mar 27. Gesundheitswesen. 2012. PMID: 22454226 Review. German.

8

Correspondence (letter to the editor): Sponsor bias.

Sawicki PT. Sawicki PT. Dtsch Arztebl Int. 2011 Oct;108(42):721-2. doi: 10.3238/arztebl.2011.0721c. Epub 2011 Oct 21. Dtsch Arztebl Int. 2011. PMID: 22114643 Free PMC article. No abstract available.

9

Not a medical course, but a life course.

Glasziou PP, Sawicki PT, Prasad K, Montori VM; International Society for Evidence-Based Health Care. Glasziou PP, et al. Among authors: sawicki pt. Acad Med. 2011 Nov;86(11):e4. doi: 10.1097/ACM.0b013e3182320ec9. Acad Med. 2011. PMID: 22030668 No abstract available.

10

Life prolonging of disease management programs in patients with type 2 diabetes is cost-effective.

Drabik A, Büscher G, Sawicki PT, Thomas K, Graf C, Müller D, Stock S. Drabik A, et al. Among authors: sawicki pt. Diabetes Res Clin Pract. 2012 Feb;95(2):194-200. doi: 10.1016/j.diabres.2011.09.015. Epub 2011 Oct 17. Diabetes Res Clin Pract. 2012. PMID: 22004943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page